Beijing Sun-Novo Pharmaceutical Research (688621.SH) co-builds a joint laboratory with Peking University Medical School.
Sunshine Pharma (688621.SH) announced that, in order to implement the national strategy for scientific and technological development, enhance independent innovation capabilities and national core competitiveness, and promote the quality and efficiency of innovative research and development work, the company is collaborating with the Beijing University Medical Department to jointly establish the "Peking University Medical-Sunshine Pharma Innovation Drug Joint Laboratory". Both parties will focus on cutting-edge areas such as cell therapy, gene therapy, and develop clinical candidate drugs as the core goal, fully leveraging their respective strengths to jointly promote the high-quality development of the company in the field of innovative drug research and development.
Beijing Sun-Novo Pharmaceutical Research (688621.SH) announced that in order to implement the national science and technology development policy, enhance independent innovation capabilities and national core competitiveness, promote the quality and efficiency of innovation research and development work, the company has collaborated with Peking University School of Medicine to jointly establish the "Peking University Medicine-Beijing Sun-Novo Pharmaceutical Research Innovative Drug Joint Laboratory." The two parties will focus on frontier areas such as cell therapy and gene therapy, with the core goal of developing clinical candidate drugs, fully leveraging their respective strengths, and jointly promoting the high-quality development of the company in the field of innovative drug research and development.
Related Articles
US Stock Market Move | Pfizer Inc. (PFE.US) fell more than 4%, with the company expecting a slowdown in revenue growth in 2026.
US Stock Market Move | Quantum computing concept stock rose, IonQ Inc (IONQ.US) rose more than 4%.
US Stock Market Move | Hesai (HSAI.US) rose more than 2%, the next generation L3 automatic driving laser radar solution will debut at CES 2026.
US Stock Market Move | Pfizer Inc. (PFE.US) fell more than 4%, with the company expecting a slowdown in revenue growth in 2026.
US Stock Market Move | Quantum computing concept stock rose, IonQ Inc (IONQ.US) rose more than 4%.
US Stock Market Move | Hesai (HSAI.US) rose more than 2%, the next generation L3 automatic driving laser radar solution will debut at CES 2026.
RECOMMEND
Super Central Bank Week Arrives! Japan Leads With A Rate Hike As Developed Economies End The Rate‑Cut Cycle, Will The Fed Cut Alone Next Year?
16/12/2025
What Guidance Does The Economic Work Conference Offer For Cross‑Year Market Direction?
16/12/2025
Trade Surplus Tops One Trillion USD: New Challenges For China’s Foreign Trade | Instant Commentary
16/12/2025
